One potential explanation for its selective therapeutic efficacy and induction of differentiation may be the specific dependency of FOXO1 and FOXO3 in AML, as evidenced by their elevated expression levels in these cells (Supplementary Fig. 5A). This evidence concerns the gene FOXO3 and acute myeloid leukemia.